No Untoward Effect of Long‐Term Ketoconazole Administration on Electrocardiographic QT Interval in Patients with Cushing's Disease-Reference-Cited by-同舟云学术

No Untoward Effect of Long‐Term Ketoconazole Administration on Electrocardiographic QT Interval in Patients with Cushing's Disease

Published:2015-10-14 Issue:4 Volume:118 Page:279-283
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

De Martin Martina¹,Toja Paola Maria²,Goulene Karine³,Radaelli Piero¹,Cavagnini Francesco¹,Stramba‐Badiale Marco³,Pecori Giraldi Francesca¹⁴

Affiliation:

1. Neuroendocrinology Research Laboratory IRCCS Istituto Auxologico Italiano Milan Italy

2. Division of Endocrinology and Metabolic Diseases IRCCS Istituto Auxologico Italiano Milan Italy

3. Department of Geriatrics and Cardiovascular Medicine IRCCS Istituto Auxologico Italiano Milan Italy

4. Department of Clinical Sciences and Community Health University of Milan Milan Italy

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.12490

Reference42 articles.

1. Drug-Induced Prolongation of the QT Interval

2. Clinical Evaluation of QT/QTc interval prolongation and proarrhythmic potential of non‐antiarrhythmic drugs.http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm073153.pdf/(last accessed on 30 October 2005).

3. Assessing risk of drugs that prolong the QT interval and cause arrhythmias.https://www.crediblemeds.org/new-drug-list// (last accessed on 30 June 2015).

4. High-Content Analysis in Toxicology: Screening Substances for Human Toxicity Potential, Elucidating Subcellular Mechanisms andIn VivoUse as Translational Safety Biomarkers

5. Systemic Antifungal Agents

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How best to monitor the specific side effects of medical treatments of Cushing’s disease;Best Practice & Research Clinical Endocrinology & Metabolism;2022-12

2. Management and Medical Therapy of Mild Hypercortisolism;International Journal of Molecular Sciences;2021-10-26

3. Levoketoconazole: a novel treatment for endogenous Cushing's syndrome;Expert Review of Endocrinology & Metabolism;2021-07-04

4. Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials;Frontiers in Endocrinology;2020-12-08

5. Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing’s syndrome;Pituitary;2020-11-20